Alongside the leadership change, Kenvue revealed that its Board had previously initiated a comprehensive review of strategic alternatives and established a Strategic Review Committee. The review will ...

The Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the ...

Recludix Pharma, a leader in the discovery of inhibitors of challenging targets for inflammatory disease, today announced that the com ...

Dateline COO to accelerate development of Colosseum Gold and REE project SYDNEY, AUSTRALIA AND SAN BERNARDINO COUNTY, CA / ...

Proposed transaction creates the broadest, most flexible portfolio of orthopedic robotics and navigation technologies to meet surgeons’ needs ...

It can be difficult keeping track of the various comings and goings in the games industry, which is why we compile ...

AlShamlan: KFH remains committed to advancing sustainable growth and aligning with national priorities under Vision 2035 ...

Jagdishan's pay package includes basic salary of Rs 3.09 crore, allowances and perquisites of Rs 3.46 crore and performance ...

Here are the eight silent killers that undermine capable leaders and the counterintuitive solutions that separate struggling CEOs from thriving ones.

(Reuters) -Tylenol maker Kenvue said on Monday Thibaut Mongon had stepped down as chief executive officer and board member. The company has named Kirk Perry as interim CEO, effective immediately.

And security spending is likely to climb in 2025 following the fatal shooting of UnitedHealthcare CEO Brian Thompson in December 2024. Experts say heightened security resources correlate to a rise in ...